{"id":210738,"name":"REGENERON PHARMACEUTICALS, INC.","slug":"regeneron-pharmaceuticals-inc","state":"NY","country":"United States of America","description":"Biopharmaceutical development and manufacturing","totalSpending":10000,"filings":20,"yearlySpending":[{"year":2021,"income":0},{"year":2022,"income":10000},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["ARNOLD & PORTER KAYE SCHOLER LLP"],"lobbyists":["EUGENIA PIERSON","MARNE MAROTTA","DAVID SKILLMAN","KEVIN O'NEILL","BOBBY MCMILLIN","SONJA NESBIT"],"govEntities":["U.S. Trade Representative (USTR)","Commerce, Dept of (DOC)","HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Engagement on trade policy developments","Engagement on international trade policy.","Engagement on international trade policy.","Engagement on international trade policy.","Engagement on international trade policy."]}